Home » Cervical Dysplasia Diagnostic Market

Cervical Dysplasia Diagnostic Market By Type (Diagnostic Test, Diagnostic Device) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Price: $4999

Published: | Report ID: 3764 | Report Format : PDF

Market Insights

Cervical carcinoma accounts for around 15% of all cancers diagnosed in women. Every year, approximately 5 lakh new cases of cervical cancer in women are reported, with developing countries accounting for 80% of these cases. Cervical dysplasia is a major health problem among women, especially in developing countries with a rising incidence of cancer. It is detected in women in their 20s, and the peak incidence ranges between 25 and 35 years, while the incidence of cervical cancer rises after 40 years. With rising awareness about cervical dysplasia, improvements in screening technology have led to early diagnosis and treatment to further avoid the progression of the disease. WHO and the national government are making efforts to build national cancer strategies based on the local need for early treatment and prevention of disease, which would help in the growth of the cervical dysplasia diagnostic market.

The report titled “Cervical Dysplasia Diagnostic Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall cervical dysplasia diagnostic market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on diagnosis type and different geographies.

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year. This section also includes additional cross-sectional analysis presented in terms of diagnosis type and constituent region/country level markets.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global cervical dysplasia diagnostic market. Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global cervical dysplasia diagnostic market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global cervical dysplasia diagnostic market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the cervical dysplasia diagnostic market. The key players profiled in this report are Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Helix BioPharma Corp., Hologic, Inc., Inovio Biomedical Corporation, Micromedic Technologies Ltd., OncoHealth Corporation, PDS Biotechnology Corporation, Photocure ASA, Quest Diagnostics, Inc., QIAGEN N.V., and others.

Based on the type of diagnosis, the global cervical dysplasia diagnostic market is segmented as follows:

Diagnostic Test

  • HPV Test
  • Pap smear examination
  • Biopsy

Diagnostic Device

  • Colposcopy

Diagnostic tests occupy the largest share, thus dominating the cervical dysplasia diagnostic market. With advancements in diagnostic technology and increased awareness about cervical dysplasia, there is a rise in screening programs for early diagnosis and treatment of the disease, which contribute to the growth of the diagnostic test segment of the cervical dysplasia diagnostic market. The Pap smear test is the most common, simple, and painless test used for detecting cervical dysplasia. However, due to errors in the results in almost 15–25% of cases, other tests, such as HPV, are being aggressively used. The HPV testing market is anticipated to grow fast in the forecast period due to advancements in technology and the preference for Pap smear tests due to false-negative results. Diagnostic devices such as colposcopies are used if the cervical cells are distinctly abnormal.

For the purpose of this study, the global cervical dysplasia diagnostic market is geographically categorized into:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

In 2016, North America dominated the global cervical dysplasia diagnostic market, followed by Europe. Annually, around 250,000 to 1 million women in the U.S. are diagnosed with cervical dysplasia. Some of the major causes of cervical dysplasia are the rising prevalence of various sexually transmitted diseases (STDs) and the adoption of unhealthy lifestyles such as drinking, smoking, and drug use. There is an increase in awareness about the occurrence and progress of cervical dysplasia, a rise in government funds for screening programs, continuously evolving diagnostic technology, and favorable reimbursement policies, which are some of the key factors contributing to the growth of the cervical dysplasia diagnostic market. Asia Pacific is anticipated to be the fastest-growing regional market in the forecast period of 2017–2025.

The rise in the prevalence of cervical cancer, increasing investment in the development of healthcare, awareness about cervical cancer, and novel diagnostic and treatment options are the key driving factors for cervical dysplasia. With the increase in mortality associated with cervical cancer, government-funded screening programs are being initiated for early diagnosis and treatment to improve the quality of life in developing countries. Emerging economies such as China and India are expected to be lucrative markets in the forecast period.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Cervical Dysplasia Diagnostic Market Portraiture
2.1.1. Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2016
2.1.2. Global Cervical Dysplasia Diagnostic Market, by Geography, 2016

Chapter 3. Cervical Dysplasia Diagnostic: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Cervical Dysplasia Diagnostic Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Cervical Dysplasia Diagnostic Market, by Type
4.3. Diagnostic Test
4.3.1. HPV Test
4.3.2. Pap Smear Test
4.3.3. Biopsy
4.4. Diagnostic Device
4.4.1. Colposcopy

Chapter 5. Global Cervical Dysplasia Diagnostic Market, by Geography, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. North America Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.2.1. North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.2.2. North America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.1.1. U.S. Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.2. Canada
5.2.2.2.1. Canada Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3. Europe Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.3.1. Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.3.2. Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.1.1. U.K. Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.2. Germany
5.3.2.2.1. Germany Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.3. Rest of Europe
5.3.2.3.1. Rest of Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4. Asia Pacific Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.4.1. Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.4.2. Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.1.1. Japan Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.2. China
5.4.2.2.1. China Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.3. Rest of Asia Pacific
5.4.2.3.1. Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5. Latin America Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.5.1. Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.5.2. Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.1.1. Brazil Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.2. Mexico
5.5.2.2.1. Mexico Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.3. Rest of Latin America
5.5.2.3.1. Rest of Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.6. Middle East & Africa (MEA) Cervical Dysplasia Diagnostic Market Analysis, 2015 – 2025
5.6.1. MEA Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
5.6.2. MEA Cervical Dysplasia Diagnostic Market, by Region, 2015 – 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.1.1. GCC Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
5.6.2.2. Rest of MEA
5.6.2.2.1. Rest of MEA Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)

Chapter 6. Company Profiles
6.1. Abbott Laboratories
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Becton, Dickinson and company
6.3. F. Hoffmann La-Roche Ltd.
6.4. Hologic, Inc.
6.5. Micromedic Technologies Ltd.
6.6. OncoHealth Corporation
6.7. PDS Biotechnology Corporation
6.8. Quest Diagnostics, Inc.
6.9. QIAGEN N.V.
6.10. Other Notable Players

List of Figures

FIG. 1 Cervical Dysplasia: Market Segmentation
FIG. 2 Global Cervical Dysplasia Diagnostic Market Share, by Type, 2016 (US$ Mn)
FIG. 3 Global Cervical Dysplasia Diagnostic Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Cervical Dysplasia Diagnostic Market, by HPV Test, 2015 – 2025 (US$ Mn)
FIG. 7 Global Cervical Dysplasia Diagnostic Market, by Pap Smear Test, 2015 – 2025 (US$ Mn)
FIG. 8 Global Cervical Dysplasia Diagnostic Market, by Biopsy, 2015 – 2025 (US$ Mn)
FIG. 9 Global Cervical Dysplasia Diagnostic Market, by Colposcopy, 2015 – 2025 (US$ Mn)
FIG. 10 U.S. Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 11 Canada Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 12 U.K. Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 13 Germany Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 14 Rest of Europe Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 15 Japan Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 16 China Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 17 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 18 Brazil Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 19 Mexico Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 21 GCC Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Cervical Dysplasia Diagnostic Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 3 North America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 4 U.S. Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 5 Canada Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 8 UK Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 9 Germany Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 10 Rest of Europe Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 13 Japan Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 14 China Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 15 Rest of Asia Pacific Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025(US$ Mn)
TABLE 17 Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 18 Brazil Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 19 Mexico America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 20 Rest of Latin America Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025(US$ Mn)
TABLE 21 Latin America Cervical Dysplasia Diagnostic Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 23 GCC Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 24 Rest of Middle East and Africa Cervical Dysplasia Diagnostic Market, by Diagnosis Type, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Cervical Dysplasia Diagnostic Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 26 Abbott Laboratories: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 27 Becton, Dickinson and company: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 28 F. Hoffmann La-Roche Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 29 Hologic, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 30 Micromedic Technologies Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 31 OncoHealth Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 32 PDS Biotechnology Corporation: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 33 Quest Diagnostics, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)
TABLE 34 QIAGEN N.V.: Company Snapshot (Business Description, Financial Information, Product Portfolio, Key Developments)

Frequently Asked Questions

What is the size of Cervical Dysplasia Diagnostic Market?

The market for Cervical Dysplasia Diagnostic Market is expected to reach US$ 791.3 Mn By 2025.

What is the Cervical Dysplasia Diagnostic Market CAGR?

The Cervical Dysplasia Diagnostic Market is expected to see significant CAGR growth over the coming years, at 6.5%.

What is the Forecast period considered for Cervical Dysplasia Diagnostic Market?

The report is forecasted from 2017-2025.

What is the base year considered for Cervical Dysplasia Diagnostic Market?

The base year of this report is 2016.

Who are the major players in this market?

Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Helix BioPharma Corp., Hologic, Inc., Inovio Biomedical Corporation, Micromedic Technologies Ltd. are some of the major players in the global market.

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

Plant Stem Cell Market

Published:
Report ID: 9766

Pharmaceutical Rapid Microbiology Testing Market

Published:
Report ID: 9476

Plant Stem Cell Nutrition Products Market

Published:
Report ID: 9775

Biological Data Visualization Market

Published:
Report ID: 32405

Bioprocess Validation Market

Published:
Report ID: 31245

Baculovirus Expression System Market

Published:
Report ID: 31033

Red Biotechnology Market

Published:
Report ID: 30876

Enzymatic DNA Synthesis Market

Published:
Report ID: 23339

Oligonucleotide API Market

Published:
Report ID: 23006

Next Generation Sequencing Market

Published:
Report ID: 14469

Small Molecule Drug Discovery Market

Published:
Report ID: 22652

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN